Aspira Pathlab Faces Selling Pressure, Declines 4.99% Amid Market Shift and Seller Dominance.
Aspira Pathlab & Diagnostics Ltd is experiencing significant selling pressure, marking a trend reversal after four days of gains. Despite a strong performance over the past week and year, the stock's current downturn contrasts with the broader market and highlights challenges within the Hospital & Healthcare Services sector.
Aspira Pathlab & Diagnostics Ltd is currently facing significant selling pressure, with the stock showing only sellers today. The stock has experienced a notable decline of 4.99%, contrasting sharply with the Sensex, which has gained 0.68%. This marks a trend reversal for Aspira, as it has fallen after four consecutive days of gains.Over the past week, Aspira Pathlab has performed well, with a 9.96% increase, but the current day's performance indicates a shift in sentiment. The stock opened with a gain of 4.99%, reaching an intraday high of Rs 75.26, before dropping to a low of Rs 68.1. Despite this downturn, the stock remains above its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages.
In terms of longer-term performance, Aspira has shown resilience, with a 58.37% increase over the past year, significantly outperforming the Sensex's 0.09% gain. However, the current selling pressure may be attributed to various factors, including market sentiment shifts and sector performance, as the Hospital & Healthcare Services sector has gained 3.09%. The stock's underperformance today, by 8.08% against its sector, highlights the current challenges faced by Aspira Pathlab & Diagnostics Ltd.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
